Global Legal Cannabis research

Legal Cannabis Comprehensive Study by Type (Indoor, Greenhouse), Application (Chronic Pain, Mental Disorders, Cancer, Others), End-Users (Healthcare Industry, Recreational Industry, Others) Players and Region - Global Market Outlook to 2026

Legal Cannabis Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Marijuana also called as cannabis, herb, pot, grass, bud, ganja, Mary Jane, and a vast number of other slang terms, it is a greenish-gray mixture of the dried flowers of Cannabis sativa. Cannabis includes sinsemilla and concentrated resins which are a stronger form of cannabis containing high doses of marijuana’s active elements which includes honeylike hash oil, waxy budder, and hard amberlike shatter. These resins are gradually common among those who use them both recreationally and medically. Changes in cannabis policies across states legalizing marijuana for medical and/or recreational use recommend that cannabis is gaining larger acceptance in our society. Marijuana legalization considers the practical uses of marijuana, especially for medical use.This growth is primarily driven by Increasing Use of Cannabis for Medical Use and Increasing Disease Burden of Chronic Pain.

Globally, a noticeable market trend is evident Rising Need for Effective Pain Management Remedies . Major Players, such as Canopy Growth Corporation (United States), Aphria, Inc. (United States), Aurora Cannabis (Canada), Wayland Group (Canada), Tilray (Canada), The Cronos Group (Canada), Organigram Holding, Inc. (Canada), GW Pharmaceuticals, plc. (United Kingdom), Lexaria Corp. (Canada) and Medicine Man Technology (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On May 2, 2019- Canopy Growth has announce that it has acquired German-based, Bionorica SE-founded C3 Cannabinoid Compound Company (“C3”) in a transformative deal that will see established single cannabinoid medicines brought together with the world’s leading full-spectrum medical cannabis offering.

Regulatory Insights:
Canada had recently passed a nationwide legalization of recreational cannabis use, following Uruguay to become the second country to do so. According to CBC, Canada is one of only two countries, besides the Netherlands, that exports cannabis products, which allows companies in Canada to gain instant revenue from recent medical cannabis

Market Drivers
  • Increasing Use of Cannabis for Medical Use
  • Increasing Disease Burden of Chronic Pain

Market Trend
  • Rising Need for Effective Pain Management Remedies
  • Legalization of Medicinal Cannabis Led To a Significant Decrease in the Black Market

Restraints
  • Excess Consumption of Cannabis affects the Brain

Opportunities
Government Earnings through Taxation
Challenges
Strict Rules and Regulations Regarding the Product Sale and Cultivation

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Legal Cannabis Study Sheds Light on
— The Legal Cannabis Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Legal Cannabis industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Legal Cannabis industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Indoor
  • Greenhouse
By Application
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
By End-Users
  • Healthcare Industry
  • Recreational Industry
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use of Cannabis for Medical Use
      • 3.2.2. Increasing Disease Burden of Chronic Pain
    • 3.3. Market Challenges
      • 3.3.1. Strict Rules and Regulations Regarding the Product Sale and Cultivation
    • 3.4. Market Trends
      • 3.4.1. Rising Need for Effective Pain Management Remedies
      • 3.4.2. Legalization of Medicinal Cannabis Led To a Significant Decrease in the Black Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Legal Cannabis, by Type, Application, End-Users and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Legal Cannabis (Value)
      • 5.2.1. Global Legal Cannabis by: Type (Value)
        • 5.2.1.1. Indoor
        • 5.2.1.2. Greenhouse
      • 5.2.2. Global Legal Cannabis by: Application (Value)
        • 5.2.2.1. Chronic Pain
        • 5.2.2.2. Mental Disorders
        • 5.2.2.3. Cancer
        • 5.2.2.4. Others
      • 5.2.3. Global Legal Cannabis by: End-Users (Value)
        • 5.2.3.1. Healthcare Industry
        • 5.2.3.2. Recreational Industry
        • 5.2.3.3. Others
      • 5.2.4. Global Legal Cannabis Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Legal Cannabis (Volume)
      • 5.3.1. Global Legal Cannabis by: Type (Volume)
        • 5.3.1.1. Indoor
        • 5.3.1.2. Greenhouse
      • 5.3.2. Global Legal Cannabis by: Application (Volume)
        • 5.3.2.1. Chronic Pain
        • 5.3.2.2. Mental Disorders
        • 5.3.2.3. Cancer
        • 5.3.2.4. Others
      • 5.3.3. Global Legal Cannabis by: End-Users (Volume)
        • 5.3.3.1. Healthcare Industry
        • 5.3.3.2. Recreational Industry
        • 5.3.3.3. Others
      • 5.3.4. Global Legal Cannabis Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Legal Cannabis (Price)
      • 5.4.1. Global Legal Cannabis by: Type (Price)
  • 6. Legal Cannabis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Canopy Growth Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aphria, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aurora Cannabis (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Wayland Group (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Tilray (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. The Cronos Group (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Organigram Holding, Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GW Pharmaceuticals, plc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lexaria Corp. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Medicine Man Technology (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Legal Cannabis Sale, by Type, Application, End-Users and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Legal Cannabis (Value)
      • 7.2.1. Global Legal Cannabis by: Type (Value)
        • 7.2.1.1. Indoor
        • 7.2.1.2. Greenhouse
      • 7.2.2. Global Legal Cannabis by: Application (Value)
        • 7.2.2.1. Chronic Pain
        • 7.2.2.2. Mental Disorders
        • 7.2.2.3. Cancer
        • 7.2.2.4. Others
      • 7.2.3. Global Legal Cannabis by: End-Users (Value)
        • 7.2.3.1. Healthcare Industry
        • 7.2.3.2. Recreational Industry
        • 7.2.3.3. Others
      • 7.2.4. Global Legal Cannabis Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Legal Cannabis (Volume)
      • 7.3.1. Global Legal Cannabis by: Type (Volume)
        • 7.3.1.1. Indoor
        • 7.3.1.2. Greenhouse
      • 7.3.2. Global Legal Cannabis by: Application (Volume)
        • 7.3.2.1. Chronic Pain
        • 7.3.2.2. Mental Disorders
        • 7.3.2.3. Cancer
        • 7.3.2.4. Others
      • 7.3.3. Global Legal Cannabis by: End-Users (Volume)
        • 7.3.3.1. Healthcare Industry
        • 7.3.3.2. Recreational Industry
        • 7.3.3.3. Others
      • 7.3.4. Global Legal Cannabis Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Legal Cannabis (Price)
      • 7.4.1. Global Legal Cannabis by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Legal Cannabis: by Type(USD Million)
  • Table 2. Legal Cannabis Indoor , by Region USD Million (2015-2020)
  • Table 3. Legal Cannabis Greenhouse , by Region USD Million (2015-2020)
  • Table 4. Legal Cannabis: by Application(USD Million)
  • Table 5. Legal Cannabis Chronic Pain , by Region USD Million (2015-2020)
  • Table 6. Legal Cannabis Mental Disorders , by Region USD Million (2015-2020)
  • Table 7. Legal Cannabis Cancer , by Region USD Million (2015-2020)
  • Table 8. Legal Cannabis Others , by Region USD Million (2015-2020)
  • Table 9. Legal Cannabis: by End-Users(USD Million)
  • Table 10. Legal Cannabis Healthcare Industry , by Region USD Million (2015-2020)
  • Table 11. Legal Cannabis Recreational Industry , by Region USD Million (2015-2020)
  • Table 12. Legal Cannabis Others , by Region USD Million (2015-2020)
  • Table 13. South America Legal Cannabis, by Country USD Million (2015-2020)
  • Table 14. South America Legal Cannabis, by Type USD Million (2015-2020)
  • Table 15. South America Legal Cannabis, by Application USD Million (2015-2020)
  • Table 16. South America Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 17. Brazil Legal Cannabis, by Type USD Million (2015-2020)
  • Table 18. Brazil Legal Cannabis, by Application USD Million (2015-2020)
  • Table 19. Brazil Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 20. Argentina Legal Cannabis, by Type USD Million (2015-2020)
  • Table 21. Argentina Legal Cannabis, by Application USD Million (2015-2020)
  • Table 22. Argentina Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 23. Rest of South America Legal Cannabis, by Type USD Million (2015-2020)
  • Table 24. Rest of South America Legal Cannabis, by Application USD Million (2015-2020)
  • Table 25. Rest of South America Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 26. Asia Pacific Legal Cannabis, by Country USD Million (2015-2020)
  • Table 27. Asia Pacific Legal Cannabis, by Type USD Million (2015-2020)
  • Table 28. Asia Pacific Legal Cannabis, by Application USD Million (2015-2020)
  • Table 29. Asia Pacific Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 30. China Legal Cannabis, by Type USD Million (2015-2020)
  • Table 31. China Legal Cannabis, by Application USD Million (2015-2020)
  • Table 32. China Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 33. Japan Legal Cannabis, by Type USD Million (2015-2020)
  • Table 34. Japan Legal Cannabis, by Application USD Million (2015-2020)
  • Table 35. Japan Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 36. India Legal Cannabis, by Type USD Million (2015-2020)
  • Table 37. India Legal Cannabis, by Application USD Million (2015-2020)
  • Table 38. India Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 39. South Korea Legal Cannabis, by Type USD Million (2015-2020)
  • Table 40. South Korea Legal Cannabis, by Application USD Million (2015-2020)
  • Table 41. South Korea Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 42. Taiwan Legal Cannabis, by Type USD Million (2015-2020)
  • Table 43. Taiwan Legal Cannabis, by Application USD Million (2015-2020)
  • Table 44. Taiwan Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 45. Australia Legal Cannabis, by Type USD Million (2015-2020)
  • Table 46. Australia Legal Cannabis, by Application USD Million (2015-2020)
  • Table 47. Australia Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Legal Cannabis, by Type USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Legal Cannabis, by Application USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 51. Europe Legal Cannabis, by Country USD Million (2015-2020)
  • Table 52. Europe Legal Cannabis, by Type USD Million (2015-2020)
  • Table 53. Europe Legal Cannabis, by Application USD Million (2015-2020)
  • Table 54. Europe Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 55. Germany Legal Cannabis, by Type USD Million (2015-2020)
  • Table 56. Germany Legal Cannabis, by Application USD Million (2015-2020)
  • Table 57. Germany Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 58. France Legal Cannabis, by Type USD Million (2015-2020)
  • Table 59. France Legal Cannabis, by Application USD Million (2015-2020)
  • Table 60. France Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 61. Italy Legal Cannabis, by Type USD Million (2015-2020)
  • Table 62. Italy Legal Cannabis, by Application USD Million (2015-2020)
  • Table 63. Italy Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 64. United Kingdom Legal Cannabis, by Type USD Million (2015-2020)
  • Table 65. United Kingdom Legal Cannabis, by Application USD Million (2015-2020)
  • Table 66. United Kingdom Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 67. Netherlands Legal Cannabis, by Type USD Million (2015-2020)
  • Table 68. Netherlands Legal Cannabis, by Application USD Million (2015-2020)
  • Table 69. Netherlands Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 70. Rest of Europe Legal Cannabis, by Type USD Million (2015-2020)
  • Table 71. Rest of Europe Legal Cannabis, by Application USD Million (2015-2020)
  • Table 72. Rest of Europe Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 73. MEA Legal Cannabis, by Country USD Million (2015-2020)
  • Table 74. MEA Legal Cannabis, by Type USD Million (2015-2020)
  • Table 75. MEA Legal Cannabis, by Application USD Million (2015-2020)
  • Table 76. MEA Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 77. Middle East Legal Cannabis, by Type USD Million (2015-2020)
  • Table 78. Middle East Legal Cannabis, by Application USD Million (2015-2020)
  • Table 79. Middle East Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 80. Africa Legal Cannabis, by Type USD Million (2015-2020)
  • Table 81. Africa Legal Cannabis, by Application USD Million (2015-2020)
  • Table 82. Africa Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 83. North America Legal Cannabis, by Country USD Million (2015-2020)
  • Table 84. North America Legal Cannabis, by Type USD Million (2015-2020)
  • Table 85. North America Legal Cannabis, by Application USD Million (2015-2020)
  • Table 86. North America Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 87. United States Legal Cannabis, by Type USD Million (2015-2020)
  • Table 88. United States Legal Cannabis, by Application USD Million (2015-2020)
  • Table 89. United States Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 90. Canada Legal Cannabis, by Type USD Million (2015-2020)
  • Table 91. Canada Legal Cannabis, by Application USD Million (2015-2020)
  • Table 92. Canada Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 93. Mexico Legal Cannabis, by Type USD Million (2015-2020)
  • Table 94. Mexico Legal Cannabis, by Application USD Million (2015-2020)
  • Table 95. Mexico Legal Cannabis, by End-Users USD Million (2015-2020)
  • Table 96. Legal Cannabis Sales: by Type(K Tons)
  • Table 97. Legal Cannabis Sales Indoor , by Region K Tons (2015-2020)
  • Table 98. Legal Cannabis Sales Greenhouse , by Region K Tons (2015-2020)
  • Table 99. Legal Cannabis Sales: by Application(K Tons)
  • Table 100. Legal Cannabis Sales Chronic Pain , by Region K Tons (2015-2020)
  • Table 101. Legal Cannabis Sales Mental Disorders , by Region K Tons (2015-2020)
  • Table 102. Legal Cannabis Sales Cancer , by Region K Tons (2015-2020)
  • Table 103. Legal Cannabis Sales Others , by Region K Tons (2015-2020)
  • Table 104. Legal Cannabis Sales: by End-Users(K Tons)
  • Table 105. Legal Cannabis Sales Healthcare Industry , by Region K Tons (2015-2020)
  • Table 106. Legal Cannabis Sales Recreational Industry , by Region K Tons (2015-2020)
  • Table 107. Legal Cannabis Sales Others , by Region K Tons (2015-2020)
  • Table 108. South America Legal Cannabis Sales, by Country K Tons (2015-2020)
  • Table 109. South America Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 110. South America Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 111. South America Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 112. Brazil Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 113. Brazil Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 114. Brazil Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 115. Argentina Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 116. Argentina Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 117. Argentina Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 118. Rest of South America Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 119. Rest of South America Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 120. Rest of South America Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 121. Asia Pacific Legal Cannabis Sales, by Country K Tons (2015-2020)
  • Table 122. Asia Pacific Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 123. Asia Pacific Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 124. Asia Pacific Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 125. China Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 126. China Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 127. China Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 128. Japan Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 129. Japan Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 130. Japan Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 131. India Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 132. India Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 133. India Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 134. South Korea Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 135. South Korea Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 136. South Korea Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 137. Taiwan Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 138. Taiwan Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 139. Taiwan Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 140. Australia Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 141. Australia Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 142. Australia Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 143. Rest of Asia-Pacific Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 144. Rest of Asia-Pacific Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 145. Rest of Asia-Pacific Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 146. Europe Legal Cannabis Sales, by Country K Tons (2015-2020)
  • Table 147. Europe Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 148. Europe Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 149. Europe Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 150. Germany Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 151. Germany Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 152. Germany Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 153. France Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 154. France Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 155. France Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 156. Italy Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 157. Italy Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 158. Italy Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 159. United Kingdom Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 160. United Kingdom Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 161. United Kingdom Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 162. Netherlands Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 163. Netherlands Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 164. Netherlands Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 165. Rest of Europe Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 166. Rest of Europe Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 167. Rest of Europe Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 168. MEA Legal Cannabis Sales, by Country K Tons (2015-2020)
  • Table 169. MEA Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 170. MEA Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 171. MEA Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 172. Middle East Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 173. Middle East Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 174. Middle East Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 175. Africa Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 176. Africa Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 177. Africa Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 178. North America Legal Cannabis Sales, by Country K Tons (2015-2020)
  • Table 179. North America Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 180. North America Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 181. North America Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 182. United States Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 183. United States Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 184. United States Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 185. Canada Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 186. Canada Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 187. Canada Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 188. Mexico Legal Cannabis Sales, by Type K Tons (2015-2020)
  • Table 189. Mexico Legal Cannabis Sales, by Application K Tons (2015-2020)
  • Table 190. Mexico Legal Cannabis Sales, by End-Users K Tons (2015-2020)
  • Table 191. Legal Cannabis: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Legal Cannabis: by Type(USD Million)
  • Table 203. Legal Cannabis Indoor , by Region USD Million (2021-2026)
  • Table 204. Legal Cannabis Greenhouse , by Region USD Million (2021-2026)
  • Table 205. Legal Cannabis: by Application(USD Million)
  • Table 206. Legal Cannabis Chronic Pain , by Region USD Million (2021-2026)
  • Table 207. Legal Cannabis Mental Disorders , by Region USD Million (2021-2026)
  • Table 208. Legal Cannabis Cancer , by Region USD Million (2021-2026)
  • Table 209. Legal Cannabis Others , by Region USD Million (2021-2026)
  • Table 210. Legal Cannabis: by End-Users(USD Million)
  • Table 211. Legal Cannabis Healthcare Industry , by Region USD Million (2021-2026)
  • Table 212. Legal Cannabis Recreational Industry , by Region USD Million (2021-2026)
  • Table 213. Legal Cannabis Others , by Region USD Million (2021-2026)
  • Table 214. South America Legal Cannabis, by Country USD Million (2021-2026)
  • Table 215. South America Legal Cannabis, by Type USD Million (2021-2026)
  • Table 216. South America Legal Cannabis, by Application USD Million (2021-2026)
  • Table 217. South America Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 218. Brazil Legal Cannabis, by Type USD Million (2021-2026)
  • Table 219. Brazil Legal Cannabis, by Application USD Million (2021-2026)
  • Table 220. Brazil Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 221. Argentina Legal Cannabis, by Type USD Million (2021-2026)
  • Table 222. Argentina Legal Cannabis, by Application USD Million (2021-2026)
  • Table 223. Argentina Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 224. Rest of South America Legal Cannabis, by Type USD Million (2021-2026)
  • Table 225. Rest of South America Legal Cannabis, by Application USD Million (2021-2026)
  • Table 226. Rest of South America Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 227. Asia Pacific Legal Cannabis, by Country USD Million (2021-2026)
  • Table 228. Asia Pacific Legal Cannabis, by Type USD Million (2021-2026)
  • Table 229. Asia Pacific Legal Cannabis, by Application USD Million (2021-2026)
  • Table 230. Asia Pacific Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 231. China Legal Cannabis, by Type USD Million (2021-2026)
  • Table 232. China Legal Cannabis, by Application USD Million (2021-2026)
  • Table 233. China Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 234. Japan Legal Cannabis, by Type USD Million (2021-2026)
  • Table 235. Japan Legal Cannabis, by Application USD Million (2021-2026)
  • Table 236. Japan Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 237. India Legal Cannabis, by Type USD Million (2021-2026)
  • Table 238. India Legal Cannabis, by Application USD Million (2021-2026)
  • Table 239. India Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 240. South Korea Legal Cannabis, by Type USD Million (2021-2026)
  • Table 241. South Korea Legal Cannabis, by Application USD Million (2021-2026)
  • Table 242. South Korea Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 243. Taiwan Legal Cannabis, by Type USD Million (2021-2026)
  • Table 244. Taiwan Legal Cannabis, by Application USD Million (2021-2026)
  • Table 245. Taiwan Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 246. Australia Legal Cannabis, by Type USD Million (2021-2026)
  • Table 247. Australia Legal Cannabis, by Application USD Million (2021-2026)
  • Table 248. Australia Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 249. Rest of Asia-Pacific Legal Cannabis, by Type USD Million (2021-2026)
  • Table 250. Rest of Asia-Pacific Legal Cannabis, by Application USD Million (2021-2026)
  • Table 251. Rest of Asia-Pacific Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 252. Europe Legal Cannabis, by Country USD Million (2021-2026)
  • Table 253. Europe Legal Cannabis, by Type USD Million (2021-2026)
  • Table 254. Europe Legal Cannabis, by Application USD Million (2021-2026)
  • Table 255. Europe Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 256. Germany Legal Cannabis, by Type USD Million (2021-2026)
  • Table 257. Germany Legal Cannabis, by Application USD Million (2021-2026)
  • Table 258. Germany Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 259. France Legal Cannabis, by Type USD Million (2021-2026)
  • Table 260. France Legal Cannabis, by Application USD Million (2021-2026)
  • Table 261. France Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 262. Italy Legal Cannabis, by Type USD Million (2021-2026)
  • Table 263. Italy Legal Cannabis, by Application USD Million (2021-2026)
  • Table 264. Italy Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 265. United Kingdom Legal Cannabis, by Type USD Million (2021-2026)
  • Table 266. United Kingdom Legal Cannabis, by Application USD Million (2021-2026)
  • Table 267. United Kingdom Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 268. Netherlands Legal Cannabis, by Type USD Million (2021-2026)
  • Table 269. Netherlands Legal Cannabis, by Application USD Million (2021-2026)
  • Table 270. Netherlands Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 271. Rest of Europe Legal Cannabis, by Type USD Million (2021-2026)
  • Table 272. Rest of Europe Legal Cannabis, by Application USD Million (2021-2026)
  • Table 273. Rest of Europe Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 274. MEA Legal Cannabis, by Country USD Million (2021-2026)
  • Table 275. MEA Legal Cannabis, by Type USD Million (2021-2026)
  • Table 276. MEA Legal Cannabis, by Application USD Million (2021-2026)
  • Table 277. MEA Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 278. Middle East Legal Cannabis, by Type USD Million (2021-2026)
  • Table 279. Middle East Legal Cannabis, by Application USD Million (2021-2026)
  • Table 280. Middle East Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 281. Africa Legal Cannabis, by Type USD Million (2021-2026)
  • Table 282. Africa Legal Cannabis, by Application USD Million (2021-2026)
  • Table 283. Africa Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 284. North America Legal Cannabis, by Country USD Million (2021-2026)
  • Table 285. North America Legal Cannabis, by Type USD Million (2021-2026)
  • Table 286. North America Legal Cannabis, by Application USD Million (2021-2026)
  • Table 287. North America Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 288. United States Legal Cannabis, by Type USD Million (2021-2026)
  • Table 289. United States Legal Cannabis, by Application USD Million (2021-2026)
  • Table 290. United States Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 291. Canada Legal Cannabis, by Type USD Million (2021-2026)
  • Table 292. Canada Legal Cannabis, by Application USD Million (2021-2026)
  • Table 293. Canada Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 294. Mexico Legal Cannabis, by Type USD Million (2021-2026)
  • Table 295. Mexico Legal Cannabis, by Application USD Million (2021-2026)
  • Table 296. Mexico Legal Cannabis, by End-Users USD Million (2021-2026)
  • Table 297. Legal Cannabis Sales: by Type(K Tons)
  • Table 298. Legal Cannabis Sales Indoor , by Region K Tons (2021-2026)
  • Table 299. Legal Cannabis Sales Greenhouse , by Region K Tons (2021-2026)
  • Table 300. Legal Cannabis Sales: by Application(K Tons)
  • Table 301. Legal Cannabis Sales Chronic Pain , by Region K Tons (2021-2026)
  • Table 302. Legal Cannabis Sales Mental Disorders , by Region K Tons (2021-2026)
  • Table 303. Legal Cannabis Sales Cancer , by Region K Tons (2021-2026)
  • Table 304. Legal Cannabis Sales Others , by Region K Tons (2021-2026)
  • Table 305. Legal Cannabis Sales: by End-Users(K Tons)
  • Table 306. Legal Cannabis Sales Healthcare Industry , by Region K Tons (2021-2026)
  • Table 307. Legal Cannabis Sales Recreational Industry , by Region K Tons (2021-2026)
  • Table 308. Legal Cannabis Sales Others , by Region K Tons (2021-2026)
  • Table 309. South America Legal Cannabis Sales, by Country K Tons (2021-2026)
  • Table 310. South America Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 311. South America Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 312. South America Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 313. Brazil Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 314. Brazil Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 315. Brazil Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 316. Argentina Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 317. Argentina Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 318. Argentina Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 319. Rest of South America Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 320. Rest of South America Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 321. Rest of South America Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 322. Asia Pacific Legal Cannabis Sales, by Country K Tons (2021-2026)
  • Table 323. Asia Pacific Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 324. Asia Pacific Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 325. Asia Pacific Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 326. China Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 327. China Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 328. China Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 329. Japan Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 330. Japan Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 331. Japan Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 332. India Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 333. India Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 334. India Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 335. South Korea Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 336. South Korea Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 337. South Korea Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 338. Taiwan Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 339. Taiwan Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 340. Taiwan Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 341. Australia Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 342. Australia Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 343. Australia Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 344. Rest of Asia-Pacific Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 345. Rest of Asia-Pacific Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 346. Rest of Asia-Pacific Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 347. Europe Legal Cannabis Sales, by Country K Tons (2021-2026)
  • Table 348. Europe Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 349. Europe Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 350. Europe Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 351. Germany Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 352. Germany Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 353. Germany Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 354. France Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 355. France Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 356. France Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 357. Italy Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 358. Italy Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 359. Italy Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 360. United Kingdom Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 361. United Kingdom Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 362. United Kingdom Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 363. Netherlands Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 364. Netherlands Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 365. Netherlands Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 366. Rest of Europe Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 367. Rest of Europe Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 368. Rest of Europe Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 369. MEA Legal Cannabis Sales, by Country K Tons (2021-2026)
  • Table 370. MEA Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 371. MEA Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 372. MEA Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 373. Middle East Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 374. Middle East Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 375. Middle East Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 376. Africa Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 377. Africa Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 378. Africa Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 379. North America Legal Cannabis Sales, by Country K Tons (2021-2026)
  • Table 380. North America Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 381. North America Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 382. North America Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 383. United States Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 384. United States Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 385. United States Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 386. Canada Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 387. Canada Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 388. Canada Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 389. Mexico Legal Cannabis Sales, by Type K Tons (2021-2026)
  • Table 390. Mexico Legal Cannabis Sales, by Application K Tons (2021-2026)
  • Table 391. Mexico Legal Cannabis Sales, by End-Users K Tons (2021-2026)
  • Table 392. Legal Cannabis: by Type(USD/Units)
  • Table 393. Research Programs/Design for This Report
  • Table 394. Key Data Information from Secondary Sources
  • Table 395. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Legal Cannabis: by Type USD Million (2015-2020)
  • Figure 5. Global Legal Cannabis: by Application USD Million (2015-2020)
  • Figure 6. Global Legal Cannabis: by End-Users USD Million (2015-2020)
  • Figure 7. South America Legal Cannabis Share (%), by Country
  • Figure 8. Asia Pacific Legal Cannabis Share (%), by Country
  • Figure 9. Europe Legal Cannabis Share (%), by Country
  • Figure 10. MEA Legal Cannabis Share (%), by Country
  • Figure 11. North America Legal Cannabis Share (%), by Country
  • Figure 12. Global Legal Cannabis: by Type K Tons (2015-2020)
  • Figure 13. Global Legal Cannabis: by Application K Tons (2015-2020)
  • Figure 14. Global Legal Cannabis: by End-Users K Tons (2015-2020)
  • Figure 15. South America Legal Cannabis Share (%), by Country
  • Figure 16. Asia Pacific Legal Cannabis Share (%), by Country
  • Figure 17. Europe Legal Cannabis Share (%), by Country
  • Figure 18. MEA Legal Cannabis Share (%), by Country
  • Figure 19. North America Legal Cannabis Share (%), by Country
  • Figure 20. Global Legal Cannabis: by Type USD/Units (2015-2020)
  • Figure 21. Global Legal Cannabis share by Players 2020 (%)
  • Figure 22. Global Legal Cannabis share by Players (Top 3) 2020(%)
  • Figure 23. Global Legal Cannabis share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Canopy Growth Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Canopy Growth Corporation (United States) Revenue: by Geography 2020
  • Figure 27. Aphria, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Aphria, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Aurora Cannabis (Canada) Revenue, Net Income and Gross profit
  • Figure 30. Aurora Cannabis (Canada) Revenue: by Geography 2020
  • Figure 31. Wayland Group (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Wayland Group (Canada) Revenue: by Geography 2020
  • Figure 33. Tilray (Canada) Revenue, Net Income and Gross profit
  • Figure 34. Tilray (Canada) Revenue: by Geography 2020
  • Figure 35. The Cronos Group (Canada) Revenue, Net Income and Gross profit
  • Figure 36. The Cronos Group (Canada) Revenue: by Geography 2020
  • Figure 37. Organigram Holding, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Organigram Holding, Inc. (Canada) Revenue: by Geography 2020
  • Figure 39. GW Pharmaceuticals, plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. GW Pharmaceuticals, plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 41. Lexaria Corp. (Canada) Revenue, Net Income and Gross profit
  • Figure 42. Lexaria Corp. (Canada) Revenue: by Geography 2020
  • Figure 43. Medicine Man Technology (United States) Revenue, Net Income and Gross profit
  • Figure 44. Medicine Man Technology (United States) Revenue: by Geography 2020
  • Figure 45. Global Legal Cannabis: by Type USD Million (2021-2026)
  • Figure 46. Global Legal Cannabis: by Application USD Million (2021-2026)
  • Figure 47. Global Legal Cannabis: by End-Users USD Million (2021-2026)
  • Figure 48. South America Legal Cannabis Share (%), by Country
  • Figure 49. Asia Pacific Legal Cannabis Share (%), by Country
  • Figure 50. Europe Legal Cannabis Share (%), by Country
  • Figure 51. MEA Legal Cannabis Share (%), by Country
  • Figure 52. North America Legal Cannabis Share (%), by Country
  • Figure 53. Global Legal Cannabis: by Type K Tons (2021-2026)
  • Figure 54. Global Legal Cannabis: by Application K Tons (2021-2026)
  • Figure 55. Global Legal Cannabis: by End-Users K Tons (2021-2026)
  • Figure 56. South America Legal Cannabis Share (%), by Country
  • Figure 57. Asia Pacific Legal Cannabis Share (%), by Country
  • Figure 58. Europe Legal Cannabis Share (%), by Country
  • Figure 59. MEA Legal Cannabis Share (%), by Country
  • Figure 60. North America Legal Cannabis Share (%), by Country
  • Figure 61. Global Legal Cannabis: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Canopy Growth Corporation (United States)
  • Aphria, Inc. (United States)
  • Aurora Cannabis (Canada)
  • Wayland Group (Canada)
  • Tilray (Canada)
  • The Cronos Group (Canada)
  • Organigram Holding, Inc. (Canada)
  • GW Pharmaceuticals, plc. (United Kingdom)
  • Lexaria Corp. (Canada)
  • Medicine Man Technology (United States)
Additional players considered in the study are as follows:
United Cannabis (United States) , Terra Tech Corp (Canada) , NuLeaf Naturals (United States) , mCig Inc. (United States)
Select User Access Type

Key Highlights of Report


Nov 2021 210 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Legal Cannabis research Quantitative research analysis
Global Legal Cannabis research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Legal Cannabis Market are Canopy Growth Corporation (United States), Aphria, Inc. (United States), Aurora Cannabis (Canada), Wayland Group (Canada), Tilray (Canada), The Cronos Group (Canada), Organigram Holding, Inc. (Canada), GW Pharmaceuticals, plc. (United Kingdom), Lexaria Corp. (Canada) and Medicine Man Technology (United States) etc.
Marijuana also called as cannabis, herb, pot, grass, bud, ganja, Mary Jane, and a vast number of other slang terms, it is a greenish-gray mixture of the dried flowers of Cannabis sativa. Cannabis includes sinsemilla and concentrated resins which are a stronger form of cannabis containing high doses of marijuana’s active elements which includes honeylike hash oil, waxy budder, and hard amberlike shatter. These resins are gradually common among those who use them both recreationally and medically. Changes in cannabis policies across states legalizing marijuana for medical and/or recreational use recommend that cannabis is gaining larger acceptance in our society. Marijuana legalization considers the practical uses of marijuana, especially for medical use.

Know More About Global Legal Cannabis research Report?

Have a Query? Click Here

Other Related Reports

Dual Chamber Syringe Comprehensive Study by Application (Liquid/Powder, Liquid/Liquid), Indication (Hemophilia, Schizophrenia, Diabetes, Erectile Dysfunction, Endometriosis, Others), Size (<1 ml, 1 m...
$ 3650
Limulus Amebocyte Lysate Comprehensive Study by Type (Bacterial Endotoxins, Pyrogens - Biological Test), Application (Drug Testing, Clinical Diagnosis, Others), End User (Hospitals, Clinics, Healthca...
$ 3450
Fragment-based Drug Discovery Comprehensive Study by Type (Fragment Screening, Fragment Optimization), End-users (Academic and Research Institutions, Biopharmaceutical Companies, Contract Research Or...
$ 3500
Baby Skin Care Comprehensive Study by Type (Natural Product, Pharmaceutical Product, Mass/Generalist Product), Application (Dry Skin, Oily Skin, Flaky Skin), Distribution Channel (Supermarket, Conven...
$ 3650
Buprenorphine Hydrochloride Comprehensive Study by Type (Tablet, Capsule), Application (Analgesic, Opioid Antagonist), Distribution Channel (Online Pharma, Hospital pharma, Retail Pharma) Players and...
$ 3500
Poliomyelitis Vaccine Comprehensive Study by Type (Oral Polio Vaccine (OPV), Inactivated Poliomyelitis Vaccine (IPV)), Application (Hospital, Clinics, Public Services, Others), Route of Administratio...
$ 3450